高剂量与低剂量缩宫素在瘦型与肥胖女性中的比较:双盲随机对照试验
该双盲随机对照试验将140名≥37周行引产的孕妇按肥胖程度分层后1:1随机接受低剂量或高剂量缩宫素,主要结局为阴道分娩时间。结果显示瘦型层和肥胖层中两组阴道分娩时间均无显著差异,但高剂量组剖宫产率在两层中均呈降低趋势。
要点
- 瘦型层阴道分娩时间低剂量组796(±411)分钟 vs 高剂量组694(±466)分钟,P=.363,无显著差异。
- 肥胖层阴道分娩时间低剂量组715(±497)分钟 vs 高剂量组762(±594)分钟,P=.733,无显著差异。
- 高剂量缩宫素组剖宫产率在瘦型层和肥胖层均呈降低趋势,但未达统计学显著。
核心结论
- 在瘦型和肥胖引产孕妇中,低剂量与高剂量缩宫素方案的阴道分娩时间均无差异。
- 观察到使用高剂量缩宫素时瘦型女性和肥胖女性的剖宫产率均呈降低趋势。
研究设计与样本
- 双盲随机对照试验,招募≥37周行引产的孕妇,按肥胖程度(肥胖与瘦型)分层后1:1随机分配至高剂量或低剂量缩宫素组。
- 共140名患者随机分组,肥胖层和瘦型层各35名接受低剂量或高剂量缩宫素。
- 主要结局为阴道分娩时间(分钟);次要结局包括总剖宫产率、因产程停滞的剖宫产、最大缩宫素输注速率、缩宫素输注中断、缩宫素输注减少、失血量、新生儿重症监护室入住和新生儿Apgar评分。
主要发现
- 瘦型层阴道分娩时间低剂量组796(±411)分钟 vs 高剂量组694(±466)分钟,P=.363。
- 肥胖层阴道分娩时间低剂量组715(±497)分钟 vs 高剂量组762(±594)分钟,P=.733。
- Kaplan-Meier曲线在瘦型层(P=.391)和肥胖层(P=.692)中低剂量与高剂量组间均无显著差异。
- 瘦型层剖宫产低剂量组5例(14.29%) vs 高剂量组2例(5.71%),P=.232;肥胖层剖宫产低剂量组4例(11.43%) vs 高剂量组1例(2.86%),P=.164。
- 产后出血发生率在瘦型层(P=0.526)和肥胖层(P=0.212)中均无差异;平均估计失血量在瘦型层(P=.472)和肥胖层(P=.215)中均无差异。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Women with obesity are likely to experience longer lengths of labor and are at an increased risk of cesarean delivery. We hypothesized that high-dose oxytocin would decrease the time to delivery in a cohort of women with obesity undergoing induction of labor. OBJECTIVE: This study aimed to assess whether women with obesity benefited from higher doses of oxytocin for induction of labor. STUDY DESIGN: A double-blinded randomized controlled trial was conducted to evaluate the effect of low-dose and high-dose oxytocin on length of labor. We recruited women who were undergoing induction of labor at ≥37 weeks of gestation. Patients were randomly assigned in a 1:1 ratio to receive low-dose or high-dose oxytocin stratified by obesity level (obese and lean). The primary outcome was length of time (minutes) to vaginal delivery. The secondary outcomes included overall cesarean delivery rate, cesarean delivery for labor arrest, maximum oxytocin infusion rate, oxytocin infusion discontinuation, oxytocin infusion decrease, blood loss, neonatal intensive care unit admission, and neonatal Apgar scores. RESULTS: A total of 140 patients were randomized into receiving low-dose and high-dose oxytocin stratified into obese and lean stratum (35 for all strata). The primary outcome, time to vaginal delivery, was similar between the low-dose and high-dose oxytocin groups in the lean stratum (796 [±411] vs 694 [±466] minutes; P=.363) and the stratum with obesity (715 [±497] vs 762 [±594] minutes; P=.733). Kaplan-Meier curves between the low-dose and high-dose oxytocin groups were not significantly different in the lean stratum (P=.391) and the stratum with obesity (P=.692). There were 5 cesarean deliveries (14.29%) in the low-dose oxytocin lean stratum vs 2 cesarean deliveries (5.71%) in the high-dose oxytocin lean stratum (P=.232). There were 4 cesarean deliveries (11.43%) in the low-dose oxytocin stratum with obesity vs 1 cesarean delivery (2.86%) in the high-dose oxytocin stratum with obesity (P=.164). There was no difference in the incidence of postpartum hemorrhage between the lean stratum (P=0.526) and the stratum with obesity (P=0.212). There was no difference in mean estimated blood loss between the lean stratum (P=.472) and the stratum with obesity (P=.215). CONCLUSION: There was no difference in time to delivery between the low-dose and high-dose oxytocin protocols in either the lean cohorts or cohorts with obesity undergoing induction of labor. We did observe a trend toward a lower rate of cesarean delivery in both lean women and women with obesity when high-dose oxytocin was used.
引用
- Wei RM, Bounthavong M, Hill MG, et al. High- vs low-dose oxytocin in lean and obese women: a double-blinded randomized controlled trial. Am J Obstet Gynecol MFM. 2022. PMID: 35358738. doi:10.1016/j.ajogmf.2022.100627
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。